Publication Name	World Journal of Diabetes
Manuscript ID	62033
Country	Türkiye

Received	2020-12-27 11:07
Peer-Review Started	2020-12-27 11:08
To Make the First Decision
Return for Revision	2021-04-20 22:51
Revised	2021-04-25 11:56
Second Decision	2021-07-07 12:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-07-07 13:56
Articles in Press	2021-07-07 13:56
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-07-14 18:58
Typeset the Manuscript	2021-07-27 04:09
Publish the Manuscript Online	2021-08-09 10:25

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Ophthalmology
Manuscript Type	Minireviews
Article Title	Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema
Manuscript Source	Invited Manuscript
All Author List	Omer Karti and Ali Osman Saatci
ORCID	Author(s) ORCID Number Omer Karti http://orcid.org/0000-0001-5085-0079 Ali Osman Saatci http://orcid.org/0000-0001-6848-7239
Funding Agency and Grant Number
Corresponding Author	Ali Osman Saatci, MD, Professor, Department of Ophthalmology, Dokuz Eylul University, İnciraltı Mahallesi Mithatpaşa cad. No. 1606 Balçova, İzmir 35330, Türkiye. osman.saatci@yahoo.com
Key Words	Dexamethasone implant; Diabetic macular edema; Diabetic retinopathy; Drug-delivery system; Glaucoma; Pharmacotherapy
Core Tip	Administration of dexamethasone (DEX) implant is among the main therapeutic alternatives for treating the diabetic macular edema (DME). Though DEX implant provides a long-standing anatomic and visual improvement, implant induced cataract progression and intraocular pressure elevation limit its clinical use as the first-line treatment but DEX implant can sometimes be the preferred option in previously vitrectomized eyes, pseudophakic eyes, and in some specific conditions where the use of vascular endothelial growth factor inhibitors is either contraindicated or suboptimal. In this mini-review, we overviewed the randomized-controlled trials, real-life clinical experiences, and meta-analyses on DEX implant treatment in DME.
Publish Date	2021-08-09 10:25
Citation	Karti O, Saatci AO. Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema. World J Diabetes 021; 12(8): 1220-1232
URL	https://www.wjgnet.com/1948-9358/full/v12/i8/1220.htm
DOI	https://dx.doi.org/10.4239/wjd.v12.i8.1220

Full Article (PDF)	WJD-12-1220.pdf
Full Article (Word)	WJD-12-1220.docx
Manuscript File	62033_Review-FilipodiaCL.docx
Answering Reviewers	62033-Answering reviewers.pdf
Audio Core Tip	62033-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	62033-Conflict-of-interest statement.pdf
Copyright License Agreement	62033-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	62033-Language certificate.pdf
Peer-review Report	62033-Peer-review(s).pdf
Scientific Misconduct Check	62033-Bing-Liu M-1.png
Scientific Misconduct Check	62033-Bing-Liu M-2.png
Scientific Misconduct Check	62033-Scientific misconduct check.pdf
Scientific Editor Work List	62033-Scientific editor work list.pdf